Literature DB >> 27816423

Burden of Recurrent Hospitalizations Following an Admission for Acute Heart Failure: Preserved Versus Reduced Ejection Fraction.

Enrique Santas1, Ernesto Valero1, Anna Mollar1, Sergio García-Blas1, Patricia Palau2, Gema Miñana1, Eduardo Núñez1, Juan Sanchis1, Francisco Javier Chorro1, Julio Núñez3.   

Abstract

INTRODUCTION AND
OBJECTIVES: Heart failure with preserved ejection fraction and reduced ejection fraction share a high mortality risk. However, differences in the rehospitalization burden over time between these 2 entities remains unclear.
METHODS: We prospectively included 2013 consecutive patients discharged for acute heart failure. Of these, 1082 (53.7%) had heart failure with preserved ejection fraction and 931 (46.2%) had heart failure with reduced ejection fraction. Cox and negative binomial regression methods were used to evaluate the risks of death and repeat hospitalizations, respectively.
RESULTS: At a median follow-up of 2.36 years (interquartile range: 0.96-4.65), 1018 patients (50.6%) died, and 3804 readmissions were registered in 1406 patients (69.8%). Overall, there were no differences in mortality between heart failure with preserved ejection fraction and heart failure with reduced ejection fraction (16.7 vs 16.1 per 100 person-years, respectively; P=0794), or all-cause repeat hospitalization rates (62.1 vs 62.2 per 100 person-years, respectively; P=.944). After multivariable adjustment, and compared with patients with heart failure with reduced ejection fraction, patients with heart failure with preserved ejection fraction exhibited a similar risk of all-cause readmissions (incidence rate ratio=1.04; 95%CI, 0.93-1.17; P=.461). Regarding specific causes, heart failure with preserved ejection fraction showed similar risks of cardiovascular and heart failure-related rehospitalizations (incidence rate ratio=0.93; 95%CI, 0.82-1.06; P=.304; incidence rate ratio=0.96; 95% confidence interval, 0.83-1.13; P=.677, respectively), but had a higher risk of noncardiovascular readmissions (incidence rate ratio=1.24; 95%CI, 1.04-1.47; P=.012).
CONCLUSIONS: Following an admission for acute heart failure, patients with heart failure with preserved ejection fraction have a similar rehospitalization burden to those with heart failure with reduced ejection fraction. However, patients with heart failure with preserved ejection fraction are more likely to be readmitted for noncardiovascular causes.
Copyright © 2016 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Heart failure; Hospitalizaciones; Hospitalizations; Insuficiencia cardiaca; Prognosis; Pronóstico

Mesh:

Year:  2016        PMID: 27816423     DOI: 10.1016/j.rec.2016.06.021

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  11 in total

1.  Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction.

Authors:  Eloy Domínguez; Patricia Palau; Eduardo Núñez; José María Ramón; Laura López; Joana Melero; Alejandro Bellver; Enrique Santas; Francisco J Chorro; Julio Núñez
Journal:  ESC Heart Fail       Date:  2018-03-24

2.  Evaluation of the HEFESTOS scale to predict outcomes in emergency department acute heart failure patients.

Authors:  Adriana Gil-Rodrigo; José María Verdú-Rotellar; Víctor Gil; Aitor Alquézar; Lluís Llauger; Pablo Herrero-Puente; Javier Jacob; Rosa Abellana; Miguel-Ángel Muñoz; María-Pilar López-Díez; Nicole Ivars-Obermeier; Begoña Espinosa; Beatriz Rodríguez; Marta Fuentes; Josep Tost; M Luisa López-Grima; Rodolfo Romero; Christian Müller; WFrank Peacock; Pere Llorens; Òscar Miró
Journal:  Intern Emerg Med       Date:  2022-08-29       Impact factor: 5.472

3.  Pharmacological treatments for heart failure with preserved ejection fraction-a systematic review and indirect comparison.

Authors:  Kwadwo Osei Bonsu; Poukwan Arunmanakul; Nathorn Chaiyakunapruk
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

4.  Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve-HR trial).

Authors:  Patricia Palau; Julia Seller; Eloy Domínguez; Inés Gómez; José María Ramón; Clara Sastre; Rafael de la Espriella; Enrique Santas; Gema Miñana; Francisco J Chorro; José Ramón González-Juanatey; Julio Núñez
Journal:  Clin Cardiol       Date:  2020-02-19       Impact factor: 2.882

5.  Validity of the Seattle Heart Failure Model after heart failure hospitalization.

Authors:  Song Li; Patrick Marcus; Julio Núñez; Eduardo Núñez; Juan Sanchis; Wayne C Levy
Journal:  ESC Heart Fail       Date:  2019-03-01

6.  Resource utilization and costs among patients with heart failure with reduced ejection fraction following a worsening heart failure event.

Authors:  Michael M Givertz; Mei Yang; Gregory P Hess; Bin Zhao; Ashwin Rai; Javed Butler
Journal:  ESC Heart Fail       Date:  2021-03-10

7.  Rehospitalization burden and morbidity risk in patients with heart failure with mid-range ejection fraction.

Authors:  Enrique Santas; Rafael de la Espriella; Patricia Palau; Gema Miñana; Martina Amiguet; Juan Sanchis; Josep Lupón; Antoni Bayes-Genís; Francisco Javier Chorro; Julio Núñez Villota
Journal:  ESC Heart Fail       Date:  2020-03-25

8.  Clinical Characteristics and Factors Associated with Heart Failure Readmission at a Tertiary Hospital in North-Eastern Tanzania.

Authors:  Abid M Sadiq; Nyasatu G Chamba; Adnan M Sadiq; Elichilia R Shao; Gloria A Temu
Journal:  Cardiol Res Pract       Date:  2020-04-30       Impact factor: 1.866

9.  Effect of insulin on readmission for heart failure following a hospitalization for acute heart failure.

Authors:  Vicente Bertomeu-Gonzalez; Lorenzo Fácila; Patricia Palau; Gema Miñana; Gonzalo Núñez; Rafael de la Espriella; Enrique Santas; Eduardo Núñez; Vicent Bodí; Francisco Javier Chorro; Alberto Cordero; Juan Sanchis; Josep Lupón; Antoni Bayés-Genís; Julio Núñez
Journal:  ESC Heart Fail       Date:  2020-08-13

Review 10.  Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?

Authors:  David M Williams; Marc Evans
Journal:  Diabetes Ther       Date:  2020-08-27       Impact factor: 3.595

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.